SOPRANO: Macitentan in pulmonary hypertension post left ventricular assist device implantation. A prospective multi-center double-blind randomized placebo-controlled parallel group study to assess the efficacy and safety of macitentan in patients with pulmonary hypertension after left ventricular assist device implantation (Protocol AC-055-205)

Study Overview

The purpose of this study is to evaluate the effect of macitentan (study drug) on the function of the heart and on the pressure in the pulmonary arteries after LVAD implantation.

Study Description

The purpose of this study is to evaluate the effect of macitentan (study drug) on the function of the heart and on the pressure in the pulmonary arteries after LVAD implantation.

Additional Information

Participants will be compensated for their participation.


  • IRB Number: 1510320657
  • Research Study Identifier: TX7537
  • Principal Investigator: I-Wen Wang, MD, PhD

Recruitment Status

Closed
Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

Contact Us

If you need help finding a study or have any questions, please contact us at inhealth@iu.edu or by phone at (888) 264-0005.